Pain driven arthrogenic muscle inhibition-mechanisms, part 1, Dr. Kacin Alan

Scientific concepts, discoveries, and phenomena

Arthrogenic muscle inhibition (AMI)

• Definition: A disruption of neurological function after joint injury that reduces the ability to fully contract muscles around the injured joint.
• Proposed role:
  • Initially protective: limits movement/forces to safeguard the joint.
  • If not resolved in rehab: can prevent effective recovery.
• Relationship to weakness:
  • AMI contributes to muscle weakness and muscle atrophy.
  • It is implicated in prolonged deficits even after rehabilitation.

Clinical populations where AMI is demonstrated

• ACL injury and ACL reconstruction (most studied; majority of evidence emphasized)
• Other conditions mentioned:
  • meniscal surgery
  • osteoarthritis
  • patellar tendinopathies
  • acute ankle sprains
  • chronic ankle instability
  • chronic low back pain

Post-ACL reconstruction weakness pattern (quadriceps focus)

• Most inhibited muscle: quadriceps femoris
• Reported strength deficit figures:
  • ~18–45% quadriceps strength deficit by week 4 post-surgery
• Recovery is slow:
  • < 10% of pre-operative strength regained by 12 weeks
  • Often incomplete recovery; ~6–30% deficit can persist for 1–6 years
  • In some cases, deficits may persist up to lifetime
• Functional consequences:
  • “Knee stiffening strategies” during walking and stairs
  • Reduced active knee motion (less extension/flexion) despite normal passive ROM
  • Limp development; longer persistence makes it harder to relearn normal kinematics

Bilateral activation deficit

• 50–70% of patients show inability to fully activate quadriceps bilaterally
• Implication: limb-symmetry calculations using the healthy leg may be unreliable.

Framework for patient functioning (ICF)

• Uses the International Classification of Functioning, Disability and Health (ICF) to connect:
  • body structure changes (e.g., ACL reconstruction)
  • patient activities
  • patient participation
• Influences:
  • Social factors: care services, social support
  • Personal factors: self-efficacy, locus of control, activity level, gender, age

---

Mechanisms contributing to AMI and muscle weakness

1) Disuse muscle atrophy (physiological)

• Triggered by: immobilization/unloading and reduced physical activity after injury
• Additional factor mentioned: changes in protein intake/diet
• Effects:
  • Reduced muscle mass
    • decreased myofilament and membrane/globular proteins
    • chronic atrophy can include reduced number of muscle cell nuclei
  • Reduced muscle quality
    • changes in motor endplate function
    • decreased capillary density
    • mitochondrial dysfunction:
      • mitochondrial enzymes decrease first; later mitochondrial number decreases
    • fiber type conversion
    • chronically, fatty infiltration

2) Arthrogenic muscle inhibition (neurological end-product of altered input)

• Triggered by: altered sensory and inflammatory/joint-related signals
• “Four Riders of the Apocalypse” (labeled):
  1. Joint swelling
  2. Proprioceptor loss / damaged mechanoreceptors (deafferentation; “loss of mechano receptors”)
  3. Laxity of the joint (loss of normal stability)
  4. Pain (very potent inhibitor of muscle contraction)
• Pain/inflammation effects:
  • Pain can instantly reduce muscle force during contraction
  • Inflammatory factors can irritate chemosensory/pain-related receptors, contributing to AMI
• Reflex and neural-level outcomes:
  • alters spinal reflexes (including reflex inhibition pathways)
  • changes cortical/supraspinal processing
• Interconnection with atrophy (vicious cycle):
  • reduced activation → worsened atrophy
  • muscle atrophy may further sustain AMI

---

Spinal reflex mechanisms of AMI (conceptual methodology/sequence)

• The talk emphasizes reflex inhibition pathways at the spinal level driven by the “four riders,” drawing on concepts summarized in a 2010 publication (Ryson/McNeur referenced).

Key spinal mechanisms described

• Flexion (withdrawal) reflex (primarily pain/inflammation driven)

  • Extending the injured knee worsens pain
  • Withdrawal reflex activates knee flexors, preventing full extension
  • Increased flexor activity inhibits alpha motor neurons supplying the quadriceps
  • Links to “knee stiffening strategies”

• Swelling-related afferent reduction

  • Joint swelling reduces discharge from Ib afferent fibers toward the spinal cord
  • This reduces excitatory drive and activates inhibitory interneuron pathways
  • Ultimately inhibits quadriceps alpha motor neurons

• Gamma loop dysfunction (proprioceptive/muscle spindle mechanism)

  • Muscle spindles sense stretch and regulate tone via gamma motor neurons
  • When proprioceptive afferents are damaged (e.g., 1a afferents), gamma motor neuron activity decreases
  • Reduced intrafusal tone leads to lower overall muscle tone and reduced muscle excitability

Important constraint

• These spinal reflexes are described as not under voluntary control.
• Therefore, patients cannot simply “override” them with intentional contraction.
• “Disinhibitory techniques” are presented as a later solution (promised in the series).

---

Progression from early to chronic AMI (time course and brain changes)

• Early phase: spinal reflex mechanisms are most active shortly after injury/surgery, then decrease over chronicity.
• Chronic AMI: supraspinal/neuroplastic changes accumulate (described using a 2021 review by Lepley & Lepley).

Major chronic mechanisms outlined

• Loss of efferent information driving inhibition earlier → later cortical reorganization
• Increased frontal/prefrontal cortical activity for motor planning:
  • more conscious planning to preserve basic function (stairs, turning, acceleration/deceleration)
• Sensory cortex changes:
  • reduced proprioceptive input increases reliance on vision
  • suggested approach: manipulate visual input to emphasize correct sensory reliance
• Reduced motor output from motor cortex to alpha motor neurons adds to spinal inhibition
• Reduced reciprocal inhibition of antagonist muscles:
  • typically, activating quadriceps inhibits knee flexors to avoid co-contraction
  • AMI can allow antagonist activation to persist → inefficient quadriceps activation → guarding/co-contraction
• Persistent AMI may contribute to neuronal morphological changes:
  • degeneration/demyelination of corticospinal pathways (axon and myelin loss from experimental evidence)
  • longer persistence implies reduced capacity for full recovery
• Behavioral/emotional adaptations resembling chronic pain:
  • fear avoidance
  • kinesiophobia
  • reduced self-efficacy
  • external locus of control

---

Treatment rationale linked to pathology

Prevent progression to irreversible changes

• Acting early is emphasized to prevent progression to changes that are harder—or impossible—to reverse.

Muscle degeneration signs (imaging-based description)

• MRI contrasts healthy vs atrophied muscles (e.g., in osteoarthritic knee):
  • reduced cross-sectional area
  • increased fat/connective tissue infiltration within muscle
  • lower force production per unit area (reduced muscle quality)
• If long-term, these muscle changes are described as partially irreversible, supporting early intervention.

---

Overall causal chain (“vicious cycle”)

• Joint injury → immobilization/unloading/unfavorable activity → disuse atrophy
• Joint injury → deafferentation (loss of proprioceptive mechanoreceptors) and altered sensory input → early spinal reflex motor inhibition
• If prolonged → neurocognitive and psychological compensation → further reduces motor output
• Decreased motor output → more atrophy/weakness → altered biomechanics and motor control (gait changes, reduced function)
• Altered movement patterns increase reinjury risk → perpetuates the cycle

---

Researchers or sources featured (as named in the subtitles)

• Dr. Alan Kacin (speaker; “Alan Kin” in subtitles)
• Ryson McNeur (2010) (paper mentioned for spinal reflex pathways)
• Lepley and Lepley (2021) (review referenced for chronic AMI mechanisms and summarized progression model)
• Additional sources referenced indirectly (e.g., “excellent review” / “literature” without named authors)